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Viruses have evolved sophisticated strategies to establish infection. Some viruses bind to cellular receptors and initiate entry, whereas others hijack cellular factors that disassemble the virus particle to facilitate entry. After delivering the viral genetic material into the host cell and the translation of the viral genes, the resulting proteins either become part of a new virus particle (or particles) or promote genome replication in a process that can be tightly coupled to virus assembly. The newly assembled progeny, in turn, undergo [morphogenesis](#Glos1){ref-type="list"}, which produces mature virions that are poised to exit the host cell. Viruses can also co-opt cellular components to suppress the innate immune system of the host to further promote infection. To accomplish these distinct steps in a typical virus life cycle --- entry, translation, replication, assembly, morphogenesis and egress --- viruses have evolved the extraordinary ability to usurp the endogenous functions of every intracellular organelle. Remarkably, whereas most organelles can support only one or a few of the steps in viral infection, one organelle --- the endoplasmic reticulum (ER) --- is involved throughout the whole viral life cycle, dependent on the specific virus. This is owing to the numerous ER-resident channels, enzymes, chaperones and sensors, as well as the physical properties of the ER lipid bilayer, including its expansive surface area and its ability to undergo constant membrane rearrangements. The large surface area of the ER also enables it to connect with several other organelles, which is probably another reason why it is used by many viruses. Therefore, the ER is not only essential in maintaining cellular homeostasis; it also renders cells particularly susceptible to viral infection.

The ER is a membranous system consisting of the outer nuclear envelope that is contiguous with an intricate network of tubules and sheets^[@CR1]^, which are shaped by resident factors in the ER^[@CR2],[@CR3],[@CR4]^. The morphology of the ER is highly dynamic and experiences constant structural rearrangements, enabling the ER to carry out a myriad of functions^[@CR5]^. In the rough, tubular ER, active protein biosynthesis occurs, whereas the sheet-like smooth ER functions in lipid metabolism and harbours detoxifying enzymes^[@CR6],[@CR7],[@CR8]^.

A major role of the ER is the biosynthesis of membrane and luminal proteins. Approximately one-third of all cellular proteins are synthesized in this organelle. During synthesis, nascent polypeptide chains are co-translationally translocated through the [SEC61 translocation channel](#Glos2){ref-type="list"}^[@CR9]^ in the ER membrane ([Fig. 1a](#Fig1){ref-type="fig"}). Luminal or secretory proteins are released from the channel into the lumen of the ER, whereas membrane proteins partition into the ER lipid bilayer. Once the newly synthesized client protein is disengaged, ER-resident enzymes carry out [post-translational modifications](#Glos3){ref-type="list"} to assist in protein folding and assembly. For example, the oligosaccharyl transferase (OST) complex attaches glycan moieties to proteins, and oxidoreductases form, break and isomerize disulfide bonds^[@CR10],[@CR11]^. Molecular [ER chaperones](#Glos4){ref-type="list"}, such as the binding immunoglobulin protein (BiP; also known as GRP78), which is a heat shock protein 70 (HSP70) ATPase, also interact with the folding client protein to prevent aggregation and render it soluble^[@CR12]^. Folded and assembled proteins are then packaged into [COPII-coated vesicles](#Glos5){ref-type="list"} and exit the ER^[@CR13]^ ([Fig. 1b](#Fig1){ref-type="fig"}), transiting through the [classical secretory pathway](#Glos6){ref-type="list"} en route to other cellular destinations or to the plasma membrane for secretion. Misfolded or misassembled proteins accumulate in the ER, which triggers a stress signalling cascade --- the unfolded protein response (UPR) --- that activates UPR sensors located on the ER membrane^[@CR14]^ ([Fig. 1c](#Fig1){ref-type="fig"}). Activation of these sensors causes an increase in the synthesis of ER-resident molecular chaperones and temporarily halts translation. If the UPR cannot remediate the misfolding of the protein, the misfolded client is retro-translocated to the cytosol where it is degraded by the proteasome in a pathway termed ER-associated degradation (ERAD)^[@CR15],[@CR16]^ ([Box 1](#Sec2){ref-type="sec"}; [Fig. 1d](#Fig1){ref-type="fig"}). The ER also controls calcium homeostasis, through different calcium channels and pumps located in the ER membrane that directly communicate with calcium channels in the plasma membrane^[@CR17]^ ([Fig. 1e](#Fig1){ref-type="fig"}). In the ER, calcium is a cofactor for chaperones, such as calnexin and calreticulin, that control glycoprotein folding, and thus has a crucial role in protein quality control^[@CR18]^. Furthermore, the ER also functions in the synthesis of lipids, including fatty acids, phospholipids, sphingolipids and cholesterol ([Fig. 1f](#Fig1){ref-type="fig"}), through strategically localized enzymes that generate lipids that become part of the membrane or signalling molecules^[@CR19]^.Figure 1Endogenous functions of the ER.**a** \| Protein biosynthesis. The endoplasmic reticulum (ER) is the site for the biosynthesis of membrane and luminal proteins that function in the ER and in the classical secretory pathway, as well as for the biosynthesis of secreted proteins. In this process, a nascent polypeptide client is co-translationally translocated through the SEC61 translocon into the lumen of the ER (for luminal proteins) or laterally into the ER bilayer (for membrane proteins). The client protein then undergoes post-translational modifications to assist in its folding and assembly --- tasks that are carried out by dedicated ER-localized enzymes or chaperones (oligosaccharyl transferase (OST), protein disulfide isomerase (PDI) family members and binding immunoglobulin protein (BiP)). **b** \| Protein secretion. After folding and assembly, the client is packaged into a coat protein complex II (COPII)-coated vesicle that buds out of the ER. The client protein is transported through the classical secretory pathway en route to other cellular destinations or to the cell surface for secretion. **c** \| Unfolded protein response (UPR). When a client protein misfolds or misassembles, it triggers the UPR, which stimulates a stress signalling cascade (through the activation of ER membrane sensors) that is intended to rectify the misfolding of proteins. **d** \| ER-associated degradation (ERAD). Despite this effort to rectify protein misfolding, if the client remains terminally misfolded, it is then subjected to degradation by a process known as ERAD. During ERAD, a misfolded substrate is processed and retro-translocated into the cytosol for proteasome-mediated degradation. **e** \| Calcium homeostasis. The ER also stores Ca^2+^ and controls its homeostasis --- a process that is regulated by different calcium channels and pumps in the ER membrane that directly communicate with calcium channels in the plasma membrane. **f** \| Lipid biogenesis. The ER is also the centre for lipid biogenesis, in which different lipid biosynthetic enzymes that are embedded and/or associated with the ER membrane generate lipids (sphingolipids, phospholipids and sterols) that are used for structural or signalling purposes. SH, sulfhydryl group.[PowerPoint slide](#MOESM17){ref-type="media"}

In this Review, we explore how these diverse functions and unique physical properties of the ER are exploited by viruses from various families, including, for example, the *Polyomaviridae, Flaviviridae* and *Reoviridae*, to promote specific steps of their life cycle ([Table 1](#Tab1){ref-type="table"}). For clarity, the multistep infection cycle will be divided into two stages: an early stage (entry-associated virus disassembly and genome translation) and a later stage (viral genome replication, assembly, morphogenesis and egress).Table 1Viruses that exploit endogenous ER functions to promote infection[PowerPoint slide](#MOESM20){ref-type="media"}FamilyStrainsER functionsMechanisms of ER exploitationRefs***Non-enveloped RNA viruses****Hepeviridae*Hepatitis E virusProtein biosynthesis, folding and assemblySynthesis of ORF2[@CR62]ERADRetro-translocation of ORF2 to the cytosol[@CR63]*Picornaviridae*PoliovirusMembrane properties and lipid biosynthesisSupport of replication[@CR60]Calcium homeostasisViroporin 2B releases Ca^2+^[@CR167]Enterovirus 71Membrane properties and lipid biosynthesisSupport of replication[@CR59]*Reoviridae*RotavirusCalcium homeostasisNon-structural protein 4 (NSP4) releases Ca^2+^ to recruit viral proteins to the site of assembly[@CR122]Membrane properties and lipid biosynthesisSupport of assembly and morphogenesis[@CR124]Protein secretionMature virion uses classical secretory pathway for egress[@CR133]***Enveloped RNA viruses****Arteriviridae*Equine arteritis virusMembrane properties and lipid biosynthesisSupport of replication[@CR90]*Coronaviridae*SARS coronavirusMembrane properties and lipid biosynthesisSupport of replication and assembly[@CR88]Mouse hepatitis virusMembrane properties and lipid biosynthesisSupport of replication*Flaviviridae*Hepatitis C virusProtein biosynthesis, folding and assemblySynthesis of the glycoproteins E1 and E2[@CR52], [@CR53]Membrane properties and lipid biosynthesisSupport of replication, assembly and morphogenesis[@CR53], [@CR67]UPRStimulation of the UPR to suppress immune responses and promote replication[@CR98]Protein secretionMature virion uses classical secretory pathway for egress[@CR131]Dengue virusProtein biosynthesis, folding and assemblySynthesis of preM and E glycoproteins[@CR50]Membrane properties and lipid biosynthesisSupport of replication and assembly[@CR91]UPRStimulation of the UPR to suppress immune responses and promote replication[@CR98]Protein secretionMature virion uses ER--Golgi recycling and the KDEL receptor for egress[@CR140]Japanese encephalitis virusProtein biosynthesis, folding and assemblySynthesis of envelope protein[@CR89]Membrane properties and lipid biosynthesisSupport of replicationUPRActivation of IRE1-dependent decay pathway to promote replication[@CR99]West Nile virusMembrane properties and lipid biosynthesisSupport of replication[@CR92]UPRNS4A and NS4B induce the UPR to promote replication[@CR168]PestivirusMembrane properties and lipid biosynthesisSupport of assembly and morphogenesis[@CR120]*Orthomyxoviridae*Influenza A virusProtein biosynthesis, folding and assemblySynthesis of the haemagglutinin glycoprotein[@CR47]UPRActivation of IRE1 to promote replication[@CR100]Calcium homeostasisIncreases IP3 to activate IP3R-mediated Ca^2+^ signalling to promote apotosis[@CR169]*Retroviridae*HIV-1Protein biosynthesis, folding and assemblySynthesis of the envelope glycoprotein[@CR46]Calcium homeostasisTat interacts with IP3R to release ER Ca^2+^ to regulate the production of TNF[@CR129]Mouse mammary tumour virusProtein biosynthesis, folding and assemblyViral protein Rem is processed by ER-resident signal peptidase[@CR65]ERADRetro-translocation of Rem to the cytosol***Non-enveloped DNA viruses****Parvoviridae*ParvovirusProtein secretionMature virion uses classical secretory pathway for egress[@CR137]*Papillomaviridae*Human papillomavirus 16ERADER-resident PDI family members are important for infection[@CR41]*Polyomaviridae*Simian virus 40Murine polyomavirusBK virusERADER-resident PDI family members partially disassemble the viruses and ER-associated cytosolic extraction machinery extracts and disassembles the viruses[@CR26], [@CR27], [@CR28], [@CR29], [@CR35], [@CR37]***Enveloped DNA viruses****Poxviridae*Vaccinia virusMembrane properties and lipid biosynthesisSupport of replication and assembly[@CR115]E, envelope protein; ER, endoplasmic reticulum; ERAD, ER-associated degradation; IP3, inositol trisphosphate; IP3R, IP3 receptor; IRE1, inositol-requiring enzyme 1; NS, non-structural; PDI, protein disulfide isomerase; preM, pre-membrane protein; SARS, severe acute respiratory syndrome; TNF, tumour necrosis factor; UPR, unfolded protein response.
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Once a nascent polypeptide is translocated into the endoplasmic reticulum (ER), a dedicated network of cellular factors ensures that it folds and matures correctly before being transported to other cellular destinations. However, protein folding is an imperfect process and when a client protein in the ER misfolds, it is ejected into the cytosol and degraded through ER-associated degradation (ERAD, see the figure). This quality control pathway relies on a cascade of enzymes and chaperones that operate in a coordinated multistep manner, which can be spatially divided into client recognition, retro-translocation, ubiquitylation, extraction and degradation. To initiate ERAD, components in the ER lumen recognize and modify the misfolded client protein and target it to the membrane-bound ERAD machinery. Next, the client protein is retro-translocated across the ER lipid bilayer through a membrane channel the central component of which is the E3 ubiquitin ligase HRD1 (also known as SYVN1). When the misfolded client protein emerges on the cytosolic side of the ER membrane, it becomes ubiquitylated by HRD1. The ubiquitylated client protein is then extracted to the cytosol by the p97-dependent extraction machinery and finally delivered to the proteasome for degradation.SH, sulfhydryl group.

Exploiting the ER during early stages of infection {#Sec3}
==================================================

***Entry-associated virus disassembly.*** The first step in viral infection is entry into the host cell. For many viruses, entry requires disassembly of the incoming virus particle. Hijacking the functions of the ER for virus disassembly during entry is best described in the *Polyomaviridae* family. Polyomaviruses are non-enveloped double-stranded DNA (dsDNA) viruses that are responsible for many human diseases, including nephropathy, [progressive multifocal leukoencephalopathy](#Glos7){ref-type="list"} and [Merkel cell carcinoma](#Glos8){ref-type="list"}^[@CR20]^. The two archetypical polyomaviruses, murine polyomavirus and simian virus 40, exhibit structural and genetic similarities to human polyomaviruses and have a similar entry mechanism to their human counterparts^[@CR20]^. Not surprisingly, studies on these two non-human polyomaviruses have provided crucial insights into the cellular basis of polyomavirus infection. Structurally, polyomaviruses are composed of 72 pentamers of the major capsid protein VP1 that enclose the DNA genome, with each pentamer encasing an internal hydrophobic protein VP2 or VP3 (Refs [@CR21],[@CR22]). The carboxyl terminus of VP1 contacts a neighbouring VP1 pentamer to provide inter-pentamer support, with intra-pentamer and inter-pentamer disulfide bonds further reinforcing the viral architecture^[@CR23]^.

Polyomaviruses undergo [receptor-mediated endocytosis](#Glos9){ref-type="list"} and traffic to the [endolysosomal system](#Glos10){ref-type="list"} from which they travel through a lipid-dependent pathway to the ER^[@CR24],[@CR25]^ ([Fig. 2a](#Fig2){ref-type="fig"}, step 1). In the ER, polyomaviruses co-opt elements of the ERAD machinery to initiate penetration into the cytosol. Specifically, redox chaperones of the protein disulfide isomerase (PDI) family isomerize and reduce the disulfide bonds in VP1, as well as unfold its C-terminal arms^[@CR26],[@CR27],[@CR28],[@CR29],[@CR30]^ ([Fig. 2a](#Fig2){ref-type="fig"}, step 2). These reactions partially disassemble polyomaviruses, exposing VP2 and VP3 (Refs [@CR27],[@CR31],[@CR32]). This generates hydrophobic virus particles that recruit BiP through the luminal [J protein](#Glos11){ref-type="list"} ER DNAJ domain-containing protein 3 (ERDJ3, also known as DNAJB11)^[@CR33]^ ([Fig. 2a](#Fig2){ref-type="fig"}, step 3). The nucleotide exchange factor 170 kDa glucose-regulated protein (GRP170; also known as HYOU1), in turn, releases polyomaviruses from BiP, enabling the hydrophobic viruses to integrate into the ER membrane^[@CR34]^ ([Fig. 2a](#Fig2){ref-type="fig"}, step 4). Imaging analyses revealed that the membrane-integrated viruses induce the reorganization of selective ER membrane proteins, including B cell receptor-associated protein 31 (BAP31; also known as BCAP31) and the J proteins DNAJ homologue subfamily B member 12 (DNAJB12), DNAJB14 and DNAJC18 (Refs [@CR32],[@CR35],[@CR36]). This rearrangement is crucial for the penetration of the ER membrane and leads to the formation of discrete puncta called foci, which are proposed as cytosol entry sites for polyomaviruses ([Fig. 2a](#Fig2){ref-type="fig"}, step 5). To complete the translocation process, the membrane-tethered cytosolic extraction machinery (composed of the heat shock cognate protein 70 (HSC70)--HSP105--small glutamine-rich tetratricopeptide repeat-containing protein-α (SGTA) complex (HSC70--HSP105--SGTA complex)) extracts the polyomaviruses into the cytosol^[@CR35],[@CR37]^ ([Fig. 2a](#Fig2){ref-type="fig"}, step 6). The extraction reaction is probably coupled to further disassembly of the virus particles, which is essential for their subsequent transport to the nucleus^[@CR37]^. Therefore, the penetration of the ER membrane by polyomaviruses illustrates how luminal, membrane and cytosolic components of the ERAD apparatus are coordinately hijacked to accomplish this decisive entry step.Figure 2Exploiting the ER during the early stages of infection.**a** \| Entry-associated disassembly. Viruses must disassemble their capsid to release their genome. Members of the *Polyomaviridae* disassemble their capsid by co-opting components of the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway. To cause infection, polyomaviruses undergo receptor-mediated endocytosis and traffic to the ER (step 1). Once at the ER, they use protein disulfide isomerase (PDI)-family members to isomerize and reduce viral disulfide bonds (step 2). These events partially disassemble the virus particles to form hydrophobic viruses that engage binding immunoglobulin protein (BiP) through the activity of ER DNAJ domain-containing protein 3 (ERDJ3; step 3). 170 kDa glucose-regulated protein (GRP170) then releases polyomavirus from BiP, enabling the hydrophobic virus to insert into the ER membrane (step 4). The membrane-inserted virus reorganizes selective ER membrane proteins (B cell receptor-associated protein 31 (BAP31) and the J proteins DNAJ homologue subfamily B member 12 (DNAJB12), DNAJB14 and DNAJ C18) in the lipid bilayer to form foci (step 5). The membrane-attached cytosolic extraction machinery (heat shock cognate protein 70 (HSC70)--heat shock protein 105 (HSP105)--small glutamine-rich tetratricopeptide repeat-containing protein-α (SGTA)) then ejects the virus from the foci into the cytosol in a reaction that simultaneously disassembles the virus (step 6). Cytosolic disassembly enables the resulting core virus particle to move into the nucleus to cause infection. **b** \| Genome translation. Some viruses exploit the ER-associated biosynthetic machinery to translate their genetic code in two ways: the translation of viral structural proteins that are incorporated into virions (for example, the envelope glycoprotein of HIV and haemagglutinin of influenza A virus (IAV)) and the translation of viral non-structural proteins that promote the subsequent viral replication step. This is evident during translation of the positive-sense RNA ((+)RNA) genome of viruses in the *Flaviviridae* (hepatitis C virus (HCV), dengue virus (DENV) and West Nile virus WNV) and *Coronaviridae* (severe acute respiratory syndrome coronavirus (SARS-CoV)) families, in which the newly synthesized replication proteins target to sites of virus replication on the ER (or ER-derived) membrane compartments in preparation for replication. At these sites, the physical architecture of the ER membrane effectively acts as a scaffold to recruit the viral replication proteins.[PowerPoint slide](#MOESM18){ref-type="media"}

The *Papillomaviridae* is the only other known virus family in which host cell entry may be associated with the ER. Although most infections that are caused by these non-enveloped DNA viruses are considered benign, some types of human papillomavirus (HPV), including HPV16 and HPV18, can lead to the formation of malignant tumours, for example cervical cancer^[@CR38]^. To enter host cells, HPV traffics from the cell surface in endocytic vesicles to the [Golgi apparatus](#Glos12){ref-type="list"} from where it continues its retrograde journey to the ER^[@CR39],[@CR40]^. Although the specific membrane penetration site for HPV remains controversial, the observation that proteins in the PDI family facilitate infection raises the possibility that papillomaviruses, similarly to polyomaviruses, hijack these redox chaperones to promote disassembly and membrane translocation^[@CR41]^. The HSP70 chaperone system has been demonstrated to disassemble HPV *in vitro*^[@CR42]^, analogous to the use of this chaperone system during the disassembly-mediated cytosol entry of polyomaviruses. After reaching the cytosol, HPV moves into the nucleus to establish infection. Intriguingly, hijacking the ERAD pathway is not limited to viruses. For example, many bacterial toxins also use this pathway during intoxication^[@CR43],[@CR44],[@CR45]^.

***Translating the viral genome.*** During entry and disassembly, the viral genome is exposed. This enables the genetic information to be transcribed and/or translated, depending on the nature of the genome (whether the genome is composed of DNA or RNA). For retroviruses, the RNA genome is first reverse transcribed to generate complementary DNA, which is the template for subsequent transcription and translation. Translation has two crucial purposes ([Table 1](#Tab1){ref-type="table"}). First, it produces viral structural proteins, such as viral envelope glycoproteins, which are necessary for the formation of virions ([Fig. 2b](#Fig2){ref-type="fig"}). For example, the envelope glycoprotein of HIV-1 and haemagglutinin of influenza A virus (IAV) are synthesized by the ER-bound biosynthetic machinery^[@CR46],[@CR47]^. Once inserted, folded and assembled, the structural proteins move to the surface of the host cell and are incorporated into new viral progeny during assembly. Other viral envelope glycoproteins (see below) are instead redirected to distinct regions of the ER membrane where virus assembly takes place. Regardless of the strategy that is used, translation, membrane insertion, folding and the assembly of enveloped proteins, arguably represent the most important ways in which all enveloped viruses exploit the functions of the ER. In fact, insights from the biosynthesis of viral envelope proteins have historically provided our earliest understanding of fundamental translocation mechanisms of the ER^[@CR48],[@CR49]^.

Second, translation can also generate viral non-structural (NS) proteins that prepare and promote the ensuing replication of the viral genome ([Fig. 2b](#Fig2){ref-type="fig"}). This is most prominently observed in positive-sense RNA ((+)RNA) viruses in which genome replication invariably occurs in association with virus-induced membranes, which are often derived from the ER. Associated with these membranes are numerous replication proteins that are translated from the viral genome. These proteins have the remarkable ability to rearrange the ER membrane, creating characteristic structures that define the virus replication sites that are referred to as \'replication factories\' or \'replication complexes\' (Ref. [@CR50]). Consequently, the physical architecture of the ER membrane is transformed into a docking station to recruit newly translated viral replication proteins that, in concert with host factors, drive and sustain replication of the viral genome.

A notable example is found in hepatitis C virus (HCV), a member of the *Flaviviridae* family. HCV is an important human pathogen that can cause chronic hepatitis, liver cirrhosis and hepatocellular carcinoma^[@CR51]^. Once its (+)RNA genome is delivered into the host cell, it is recruited to the ER membrane for translation. Translation of the viral RNA produces a single polyprotein, which is processed by viral and cellular proteases to generate 10 distinct protein products: structural proteins that consist of the core protein and the envelope glycoproteins E1 and E2, as well as the p7 [viroporin](#Glos13){ref-type="list"} and the non-structural proteins NS2, NS3, NS4A, NS4B, NS5A and NS5B. Among these, NS3, NS4A, NS4B, NS5A and NS5B are necessary and sufficient for RNA replication, whereas p7 and NS2 are involved in the subsequent assembly step^[@CR52],[@CR53]^. Importantly, the five replication proteins coordinately target to the cytosolic surface of the ER membrane, a process that is facilitated by the fact that NS4A, NS4B and NS5B are transmembrane proteins^[@CR53]^. These replication proteins induce the formation of the replication site.

A similar process is observed during infection with dengue virus (DENV) and West Nile virus (WNV), two additional members of the *Flaviviridae* family. Infection with DENV can be associated with dengue haemorrhagic fever^[@CR54]^, while infection with WNV can also cause severe human disease, including encephalitis and meningitis^[@CR55]^. For both viruses, the ER-dependent translation of their (+)RNA genomes generates a single polyprotein^[@CR56]^. Proteolytic cleavage of the polyprotein results in 10 mature viral proteins, comprising three structural proteins --- capsid protein (C), pre-membrane protein (preM) and envelope protein (E) --- and seven non-structural counterparts: NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5. As transmembrane proteins, NS2A, NS4A and NS4B are strategically positioned on the ER membrane where they establish the eventual viral replication factory, similar to HCV. The general strategy of targeting viral replication proteins to the ER membrane where they induce membrane rearrangements to form the viral replication site is also observed during infection with members of the *Coronaviridae* family^[@CR57]^ ([Table 1](#Tab1){ref-type="table"}). There is evidence that members of the *Picornaviridae* family, such as poliovirus and enterovirus 71 (EV71), use a similar strategy^[@CR58],[@CR59],[@CR60]^. Therefore, these examples elegantly demonstrate how diverse viruses have evolved conserved mechanisms to exploit the protein biosynthetic machinery and trafficking pathways that are associated with the ER, as well as the large surface area of the ER membrane, to recruit viral proteins and promote the formation of viral replication sites.

Intriguingly, although the typical function of the translocation machinery of the ER can be subverted to translate viral structural and non-structural proteins, more unconventional use of this apparatus may also be possible. For example, hepatitis E virus (HEV), a (+)RNA non-enveloped virus that causes inflammation of the liver^[@CR61]^, uses the translocation machinery of the ER to deliver the capsid protein ORF2 into the ER^[@CR62]^. However, after reaching the lumen of the ER, ORF2 seems to be glycosylated and retro-translocated back to the cytosol by co-opting the ERAD pathway^[@CR63]^. The ORF2 capsid protein subsequently evades proteasomal degradation in the cytosol by an unknown mechanism, and is presumably available for virus assembly^[@CR63]^. Why ORF2 is translocated into the lumen of the ER, as well as whether this \'in-and-out\' transport pathway occurs during bona fide infection, remain to be addressed. The use of this unusual pathway is also observed during the synthesis of the Rem protein of mouse mammary tumour virus (MMTV), a retrovirus that is responsible for murine mammary carcinoma, which is used as a model to study breast cancer^[@CR64]^. Rem is a virus-encoded, nuclear-localized protein that controls viral mRNA export from the nucleus to the cytosol. For Rem to reach the nucleus, it first co-translationally translocates into the ER, where it is processed by [ER-resident signal peptidase](#Glos14){ref-type="list"} before being retro-translocated back to the cytosol, from where it enters the nucleus^[@CR65]^. To date, the physiological significance of this unconventional pathway in Rem function remains unclear. Nonetheless, these examples reveal novel ways by which viruses usurp ER translocation and retro-translocation, thereby coupling these two opposing membrane transport pathways, which is not observed during their normal cellular functions.

Co-opting the ER during later stages of infection {#Sec4}
=================================================

***Viral genome replication.*** Once a virus enters the host cell, its genetic information is transcribed and translated to generate viral proteins, including replication proteins. When these replication proteins are strategically positioned on the ER membrane, the host cell is ready to support the replication of the viral genome and the subsequent assembly of new progeny virions, with assistance from cellular components. In many instances, viral replication and assembly are tightly coupled. Although these two events can occur in other intracellular organelles, depending on the virus, the ER is the most common site of replication and assembly^[@CR66]^. As introduced above, numerous viruses in the (+)RNA *Flaviviridae, Coronaviridae* and *Picornaviridae* families exploit the ER to initiate and sustain viral replication and assembly ([Table 1](#Tab1){ref-type="table"}). With the exception of retroviruses, almost all RNA viruses use virus-encoded RNA-dependent RNA polymerases for RNA replication. Replication occurs in virus-induced membranous structures that are most often derived from the ER and have different morphologies and terminologies^[@CR50]^ ([Fig. 3a](#Fig3){ref-type="fig"}). Regardless of the classification, these replication sites act to increase the local concentrations of viral and host components that are essential for RNA replication, enable different steps of the replication reactions to be coordinated efficiently, and guard against the host innate immune system. Transcription of a negative-sense RNA ((−)RNA) intermediate at replication sites is then used for the synthesis of (+)RNA genomes, which are packaged into new virions during assembly. We will use ER-associated replication and assembly of HCV as the framework to understand these processes owing to the wealth of information that is available, although relevant examples from other viruses will be discussed.Figure 3Co-opting the ER to promote the later stages of infection.Viruses can co-opt functions that are associated with the endoplasmic reticulum (ER) to achieve the four crucial later steps in infection --- replication, assembly, morphogenesis and egress. **a** \| Genome replication. During this process, the replication proteins of numerous viruses rearrange the ER membrane to generate membranous structures with different morphologies and terminologies, such as invaginated vesicles (for dengue virus (DENV) and West Nile virus (WNV)) and double-membrane vesicles (DMVs; for hepatitis C virus (HCV), poliovirus and enterovirus 71 (EV71)). These replication sites act to increase the local concentrations of viral and host components that are essential for RNA replication, and enable different steps of the replication process to be coordinated efficiently. **b** \| Assembly. Virus assembly can be tightly coupled to, and coordinated with, genome replication, as exemplified in HCV. To initiate the assembly of viral progeny, a lipid droplet recruits viral core proteins to its surface and delivers them to the site of assembly. In one model of HCV virion assembly, core proteins capture the newly replicated positive-sense RNA ((+)RNA) that extrudes from the neighbouring DMV, forming the nucleocapsid. The nucleocapsid may then bud into the lumen of the ER, generating a newly assembled enveloped virus particle that contains the structural glycoproteins E1 and E2. **c** \| Morphogenesis. Morphogenesis of the assembled HCV particle continues in the ER, with the acquisition of lipoproteins on its surface to generate the mature \'lipoviral\' HCV particle that is poised to exit the host cell. For rotavirus, ER-dependent morphogenesis is initiated when its membrane protein non-structural protein 4 (NSP4) induces calcium release from the ER. This triggers a signalling cascade that delivers the structural proteins VP4 and VP7, with assistance from NSP4, to the ER membrane assembly site. The VP4--NSP4--VP7 complex recruits the double-layer particle (DLP) and deforms the membrane to form a transient enveloped intermediate in the lumen of the ER. Following the removal of the ER-derived lipid bilayer, VP7 correctly assembles on the surface of the mature infectious triple-layer particle (TLP), with the simultaneous release of NSP4. The morphologically matured virion then exits the host cell through lysis or secretion. **d** \| Egress. The final step of infection is egress of the mature virion. Viruses that mature in the ER co-opt the ER-dependent secretory pathway to access the extracellular milieu. Examples of using this strategy can be found in egress of the mature HCV, rotavirus and parvovirus particles. Additionally, the ER could also have specific components, such as the KDEL receptor in the case of DENV, that are hijacked to promote exit. COPII, coat protein complex II.[PowerPoint slide](#MOESM19){ref-type="media"}

The viral replication proteins of HCV induce extensive membrane rearrangements, forming ER-derived double-membrane vesicle (DMV) structures that are designed to support RNA replication^[@CR67]^. These structures are embedded in a membranous matrix that is juxtaposed to the ER membrane and is known as the \'membranous web\' (Refs [@CR68],[@CR69]). The identification of viral replicase components and replicase activity associated with purified DMVs argues strongly that these structures are responsible for the replication of the HCV genome, which is consistent with the finding that the kinetics of viral genome replication temporally coincide with the formation of DMVs^[@CR53],[@CR70]^. Mechanistically, the biogenesis of DMVs requires substantial structural changes to the ER membrane, which involve membrane deformations, extensions and contractions to generate the appropriate topology. These morphological alterations are probably aided by the intrinsic plasticity of the ER membrane, which typically undergoes constant rearrangements. Topologically, it should be stressed that, as the viral replication proteins are associated with the cytoplasmic surface of the ER membrane, replication of the viral genome occurs in the cytoplasm.

The concerted action of all five viral replication proteins is essential for the formation of DMVs, with NS4B and NS5A probably having central roles^[@CR71],[@CR72],[@CR73]^. However, an increasing number of host factors also contribute to the formation of DMVs^[@CR53]^. For example, NS5A and NS5B target the host lipid kinase phosphatidylinositol 4-kinase-α (PI4Kα) to the ER-derived membrane, which stimulates its activity to locally produce phosphatidylinositol-4-phosphate (PI4P)^[@CR74],[@CR75],[@CR76],[@CR77]^. PI4P is responsible for numerous cellular processes, including signal transduction, actin organization and membrane trafficking^[@CR78]^, and can control membrane curvature^[@CR79],[@CR80]^, which might enable it to directly regulate the formation of DMVs^[@CR78]^. Alternatively, or additionally, PI4P recruits the cellular oxysterol-binding protein to sites of viral replication, which leads to cholesterol enrichment that is thought to be crucial for the replication of the viral genome through an undefined mechanism^[@CR81],[@CR82]^. This is especially important as the ER membrane has a low concentration of cholesterol^[@CR7]^. Another protein that is targeted to the DMV (by NS4B) is the proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2)^[@CR83]^. This host protein is of interest because it contains a Bin--amphiphysin--Rvs domain ([F-BAR domain](#Glos15){ref-type="list"}) that has the ability to alter membrane curvature, which raises the possibility that PSTPIP2 shapes the ER membrane to generate the DMV^[@CR84]^.

In the case of poliovirus, the viral replication proteins 2BC and 3A induce the necessary alterations to the ER membrane that trigger the formation of DMVs^[@CR60]^, although the Golgi apparatus might contribute to the production of DMVs^[@CR85]^. The 2C replication protein of EV71 acts in a similar capacity, in part, through the recruitment of the ER membrane protein reticulon 3 (RTN3), which is known to alter membrane curvature in the ER^[@CR2],[@CR59]^. As both of these viruses form DMVs, it is perhaps not surprising that they also rely on the production of PI4P for their replication^[@CR86],[@CR87]^. Intriguingly, the nsp3, nsp4 and nsp6 membrane proteins of murine hepatitis virus drive the formation of a modified DMV (known as EDEMsome) that contains a subset of ERAD regulators to support viral replication^[@CR88]^. The formation of this modified DMV has also been reported for Japanese encephalitis virus (JEV) in the *Flaviviridae* family and the equine arteritis virus (EAV) in the *Arteriviridae* family^[@CR89],[@CR90]^ ([Table 1](#Tab1){ref-type="table"}). Whether PI4P is essential during the replication of these viruses is unknown.

Other virus-induced, ER-derived membranous structures that are used to support viral replication but are morphologically distinct from the DMV, are invaginated vesicles (initially characterized as convoluted membranes and vesicle packets)^[@CR67],[@CR91],[@CR92],[@CR93]^. DENV and WNV use their non-structural proteins NS4A and NS4B^[@CR94],[@CR95]^ to trigger the formation of invaginated vesicles to promote their genome replication. Importantly, the direct visualization of double-stranded RNA (dsRNA; a replication marker) in the interior of the DENV-induced, ER-derived structure provides strong evidence that it acts as the site of RNA replication^[@CR93]^. Topologically, both the DMV and invaginated vesicles are membranous structures that seem to remain mostly attached to the ER membrane^[@CR71],[@CR93]^. Despite being closely related to HCV, the replication of DENV and WNV does not require PI4P^[@CR96],[@CR97]^. Therefore, it is tempting to speculate that PI4P is essential for the replication of viruses that use the DMV, but not for viruses that use invaginated vesicles, as their site of replication. Regardless, the general idea of recruiting viral replication proteins to the ER membrane to create a replication factory (DMV or invaginated vesicles) to promote genome replication seems to be a broad principle that is shared across different virus families.

Apart from exploiting the propensity of the ER to undergo membrane rearrangements and its role in lipid biogenesis, ER-dependent UPR signalling is also hijacked to support viral replication. For example, HCV and DENV stimulate the UPR to promote viral replication through the impairment of the host antiviral innate immune response, whereas JEV activates the UPR to facilitate viral replication through controlling the [inositol-requiring enzyme 1 (IRE1)-dependent decay pathway](#Glos16){ref-type="list"}^[@CR98],[@CR99]^. IAV also triggers the UPR to support viral replication through the activation of IRE1, although how the induction of IRE1 promotes viral replication remains unknown^[@CR100]^. As there are numerous examples of viruses using the UPR to regulate their life cycle, we refer the reader to several recent reviews on this topic^[@CR101],[@CR102],[@CR103],[@CR104],[@CR105]^.

***Virus assembly.*** Although viral replication and assembly are often thought to be tightly coupled processes, how these two events are precisely interlinked is poorly understood. Nonetheless, a model has been developed for HCV. Although viral genome replication occurs at the ER-derived DMV, the site of virus assembly is less clear but could possibly involve distinct regions of an ER-derived membrane ([Fig. 3b](#Fig3){ref-type="fig"}). An essential host component that couples viral replication and assembly is the lipid droplet, a cellular storage organelle of neutral lipids^[@CR106]^. Owing, in part, to the small GTP-binding protein RAB18, lipid droplets can localize proximal to the DMV^[@CR107]^. In addition, the amphipathic helices of the NS4B protein of HCV have been reported to bind to lipid droplets, which may contribute to their recruitment^[@CR108]^. Situated next to the DMV, the key function of lipid droplets is to recruit the HCV core protein to its surface ([Fig. 3b](#Fig3){ref-type="fig"}), assisted by cellular enzymes that maintain lipid homeostasis. Subsequently, core proteins are thought to be released from lipid droplets and delivered to an assembly site on what is presumed to be the ER membrane (or at least an ER-derived membranous structure; [Fig. 3b](#Fig3){ref-type="fig"}). At the assembly site, core proteins encapsulate the newly replicated (+)RNA that is extruded from the nearby DMV, forming the nucleocapsid ([Fig. 3b](#Fig3){ref-type="fig"}). These reactions are mediated by p7, NS2, NS3 and NS4A^[@CR109],[@CR110],[@CR111],[@CR112],[@CR113]^. After formation, the nucleocapsid is thought to bud into the lumen of the ER, producing a newly assembled, enveloped virion that contains the surface glycoproteins E1 and E2 ([Fig. 3b](#Fig3){ref-type="fig"}). In the *Flaviviridae* family, interaction between the capsid protein of DENV and lipid droplets in the host has also been reported to be important for virus replication and assembly^[@CR114]^.

The coupling of replication and assembly that relies on the ER membrane is not a strategy that is exclusive to RNA viruses. For example, imaging studies have revealed that vaccinia virus, a large enveloped DNA virus in the *Poxviridae* family, uses the ER membrane during its replication and assembly^[@CR115]^. Intriguingly, the membrane surface of the resulting viral progeny corresponds to the luminal side of the ER membrane without necessarily budding into the ER membrane. How this perplexing topology is achieved clearly requires further investigation, but may involve an unusual membrane rupture step^[@CR116]^. PI4P was recently implicated in the replication and assembly of poxviruses, similar to the use of this lipid during the replication of HCV, poliovirus and EV71 (Ref. [@CR117]).

***Viral morphogenesis.*** Once new virus particles are assembled, they typically undergo further morphogenesis to generate mature virions that are poised to egress from the host cell. Subverting the functions of the ER to support these pivotal steps in late infection has been well documented for certain viruses. For example, after assembly of the HCV particle in the ER (or ER-derived) membrane, HCV undergoes additional maturation steps to egress from the host, including the acquisition of lipoproteins, particularly apolipoprotein E, on its surface^[@CR118]^ ([Fig. 3b](#Fig3){ref-type="fig"}). Surface lipoproteins probably explain the rather heterogeneous morphology of mature infectious virions^[@CR119]^. The ER has also been reported to regulate morphogenesis of pestiviruses in the *Flaviviridae* family^[@CR104]^, and hepatitis B virus (HBV) in the *Hepadnaviridae* family^[@CR120],[@CR121]^. During the propagation of HBV, a non-infectious HBV subviral envelope particle (SVP) is produced. Intriguingly, SVP morphogenesis from its initial filamentous form to mature spherical particles that are ready for secretion is thought to be initiated in the perinuclear ER^[@CR121]^.

Perhaps the most remarkable case of ER-dependent viral morphogenesis is found during the maturation of rotavirus, a member of the *Reoviridae* family and a causative agent of severe infant and childhood diarrhoea. Structurally, this non-enveloped dsRNA virus contains three concentric layers, the inner (core shell), middle and outer layers, which are composed of VP2, VP6, VP7 and VP4, respectively. The combination of the core shell and middle layer is called the double-layer particle (DLP), whereas the addition of the outer layer to the DLP forms the mature infectious virus called the triple-layer particle (TLP). Morphogenesis of the DLP to the TLP is uniquely associated with the ER ([Fig. 3c](#Fig3){ref-type="fig"}).

The morphogenesis of the DLP to the TLP is initiated when the rotavirus non-structural membrane protein NSP4, which acts as a viroporin, binds to the ER membrane and induces the release of calcium into the cytosol^[@CR122]^ ([Fig. 3c](#Fig3){ref-type="fig"}). The subsequent rise in cytosolic calcium activates a kinase-dependent signalling cascade that triggers [autophagy](#Glos17){ref-type="list"} ([Fig. 3c](#Fig3){ref-type="fig"}). This membrane trafficking pathway is then used to deliver rotavirus structural proteins VP4 and VP7 to the site of virus assembly on the ER membrane ([Fig. 3c](#Fig3){ref-type="fig"}). At this juncture, NSP4 carries out several crucial functions, including interactions with VP4 on the cytosolic side of the ER membrane, and VP7 on the luminal side that remains loosely associated with NSP4. NSP4 also binds to the DLP, targeting it to the cytosolic side of the ER membrane. Next, the newly formed DLP--VP4--NSP4--VP7 complex drives membrane deformation, which generates a transient enveloped intermediate in the lumen of the ER ([Fig. 3c](#Fig3){ref-type="fig"}). As a consequence of this inward budding event, VP7 is displayed on the surface of the enveloped intermediate. Removal of the ER-derived lipid bilayer then enables the assembly of VP7 on the surface of the mature infectious TLP, with the concomitant release of NSP4 from the DLP ([Fig. 3c](#Fig3){ref-type="fig"}). Finally, the TLP exits the host cell by lysis or secretion. Perhaps the most enigmatic step during these ER-dependent remodelling events is how the lipid bilayer that encompasses the transient enveloped intermediate becomes \'solubilized\'. One possibility is the use of the viral structural protein VP7, which has membrane lytic activity^[@CR123]^. In this scenario, the conformational change that accompanies the assembly of VP7 might expose its lytic domain, enabling VP7 to disrupt the integrity of the membrane. Whether components of the ER are exploited to facilitate the removal of the membrane is also unclear. In this regard, there is evidence that the ER-resident chaperone BiP and the oxidoreductase PDI support rotavirus morphogenesis in the ER^[@CR124]^, although their roles may be indirect and instead be co-opted to assist in the conformational changes of VP7. Therefore, rotavirus morphogenesis seems to exploit three distinct functions and characteristics that are associated with the ER: intraluminal calcium efflux (to trigger the cytosolic signalling cascade), active rearrangement of the ER membrane (ideally suited for the inward budding reaction), and the use of ER-resident folding chaperones and enzymes (to promote the formation of the TLP).

Similar to NSP4 from rotavirus, other viral proteins also disrupt the ER membrane to stimulate the release of calcium from the ER, including the 2B and 2BC proteins of EV71 and rhinovirus, as well as the pUL37×1 protein of human cytomegalovirus^[@CR125],[@CR126],[@CR127]^. Furthermore, the Tat protein of HIV-1 can activate the ryanodine and inositol trisphosphate (IP3) receptors to mobilize calcium from the ER into the cytosol^[@CR128],[@CR129],[@CR130]^. Although calcium release does not seem to be directly linked to facilitating viral morphogenesis in these examples, they nonetheless highlight the widespread use of viral components to cause calcium efflux from the ER to regulate aspects of the infection process.

***Viral egress.*** Egress of the mature virion represents the final step in the viral life cycle. Essentially all viruses exit the host cell by being released into the extracellular milieu. Viruses that assemble and mature in the ER take advantage of the ER-associated biosynthetic machinery that enables the synthesis of viral structural proteins. Moreover, they use the ER-dependent secretory pathway to reach the plasma membrane for the release of viruses into the extracellular environment ([Fig. 3d](#Fig3){ref-type="fig"}). For example, after envelopment in the ER, the new HCV particles are thought to use components of the classical secretory pathway for egress^[@CR131]^, although a recent report implicated the clathrin-dependent pathway as another possibility for HCV egress^[@CR132]^. In addition, there is evidence that rotavirus, following ER-dependent morphogenesis, uses the classical secretory pathway for exit^[@CR118]^; a non-conventional egress strategy has also been proposed^[@CR133],[@CR134]^. Although non-enveloped viruses are typically released through cell lysis, there are examples in which active vesicular transport is involved^[@CR135],[@CR136]^. The progeny of parvovirus are packaged into COPII-coated vesicles in the ER before being transported to the Golgi apparatus en route to the plasma membrane for egress^[@CR137]^. Interestingly, COPII-dependent vesicular budding was reported to be essential during infection with poliovirus, although this pathway is more likely to be involved in the formation of its genome replication site than in egress^[@CR138],[@CR139]^.

In addition to providing a simple conduit to the cell surface, the ER could harbour specific factors that directly promote exit from the host cell. In fact, the discovery that the ER-resident KDEL receptor, a receptor that normally cycles cellular client proteins between the ER and the Golgi apparatus, is hijacked by DENV for host cell exit represents an excellent example of this possibility^[@CR140]^ ([Fig. 3d](#Fig3){ref-type="fig"}). Future studies will undoubtedly reveal other host components in the ER-dependent secretory pathway that guide viral egress. It is interesting to note that apart from the ER-dependent secretory pathway, autophagosomes that are derived from the ER can also be exploited for viral egress^[@CR141],[@CR142]^.

Antiviral strategies targeting the ER {#Sec5}
=====================================

As viruses exploit the ER during infection, pharmacological strategies that are aimed at disrupting the function of the ER should, in principle, lead to the generation of broad-spectrum antiviral agents. Indeed, drugs that impair the ER-resident glycan-trimming enzymes α-glucosidase I and α-glucosidase II have been shown to block infection with DNA viruses, including herpes simplex virus 2, cytomegalovirus and HBV, as well as RNA viruses, such as HIV, HCV, JEV and WNV^[@CR143]^. As these enzymes remove glucose residues in *N*-linked glycans that are attached to newly synthesized proteins and are important for correct folding, the inhibition of α-glucosidase is expected to disrupt the function of the newly synthesized viral glycoproteins. Targeting the UPR pathway could also prove useful^[@CR103],[@CR144],[@CR145],[@CR146]^. Another possibility is to manipulate the ERAD system, as numerous viruses are known to exploit ERAD to evade the host innate immune system and sustain infection ([Box 2](#Sec6){ref-type="sec"}). In this situation, impairing ERAD may help to boost host immunity during infection. An orally active inhibitor against a key ERAD regulator --- p97---was recently identified^[@CR147],[@CR148]^; whether this inhibitor can limit virus infection remains to be seen. The cytosolic chaperone HSP70 and its cohort of co-chaperones also control ERAD^[@CR149],[@CR150]^. Because of the connection that flaviviruses have to the ERAD pathway^[@CR89],[@CR151],[@CR152]^, it is perhaps not surprising that a recent report identified a chemical inhibitor of HSP70 that blocked infection by members of this family^[@CR153]^. Finally, drugs that target lipid synthesis and metabolism in the host have also been demonstrated to inhibit infection with DENV and HCV, most likely by affecting functions that are associated with the ER^[@CR154]^. Clearly the most important criterion in the effort to develop effective antiviral therapies by targeting endogenous functions of the ER will be to minimize toxicity against the host cell.

 {#Sec6}

The host immune system can activate an antiviral response. However, several viruses have evolved strategies to dampen this immune response by manipulating functions of the endoplasmic reticulum (ER), thereby promoting their infection^[@CR155],[@CR156]^. One well-characterized example comes from the *Herpesviridae* family, in which viruses evade host immunity by suppressing or eliminating host immune factors. For example, the human cytomegalovirus transmembrane proteins US2 and US11 trigger ER-associated degradation (ERAD)-dependent proteasomal degradation of the host antigen-presenting major histocompatibility complex (MHC) class I molecule^[@CR157],[@CR158]^. Similarly, the mK3 (also known as MIR1) E3 ligase of murine gammaherpesvirus 68 and the pK3 E3 ligase of rodent herpesvirus Peru ubiquitylate MHC class I to promote its ERAD-mediated degradation^[@CR159],[@CR160]^. The absence of MHC class I impedes viral antigens from being correctly displayed on the surface of infected cells, thereby preventing the host from mounting an effective immune response. Interestingly, other viruses in the *Herpesviridae* family (herpes simplex virus, Epstein--Barr virus and varicella virus) evade the host immune response by blocking transporter associated with antigen processing (TAP)-mediated peptide transport into the ER, which consequently prevents peptide assembly with MHC class I^[@CR161],[@CR162],[@CR163]^. During infection with HIV-1, the viral Vpu protein co-opts the ERAD pathway to degrade the CD4 host cell entry receptor^[@CR164],[@CR165]^, which surprisingly results in more vigorous HIV infection. For example, the degradation of CD4 has been shown to stimulate the release of new viral progeny from the host cell surface^[@CR166]^.

Conclusion {#Sec7}
==========

Efforts to develop therapies against viruses that cause debilitating human diseases have uncovered unparalleled insights into the dynamic relationship between viruses and host cells. This interplay is evident in the ER, where viruses have evolved elegant strategies to exploit intrinsic functions of the ER to promote every stage of infection. For example, members of the *Polyomaviridae* co-opt ERAD to disassemble and to access the cytosol of the host cell. Members of the *Flaviviridae*, *Coronaviridae* and *Picornaviridae* take advantage of the propensity for structural rearrangements in the ER membrane, sculpting this membrane to create ER-derived replication and assembly sites. The non-enveloped rotavirus exploits the physical properties of the ER and the presence of pro-folding chaperones to facilitate morphogenesis in the lumen of the ER. Despite these detailed understandings, many crucial questions remain. During virus entry, do polyomavirus-induced structures on the ER membrane act as the site of entry to the cytosol? Do new HCV particles assemble directly on the ER membrane or instead on an ER-derived membranous structure? During morphogenesis, how does rotavirus lose its transient lipid bilayer in the lumen of the ER to generate the infectious TLP virion? What is required to address these and other outstanding questions is a comprehensive strategy that combines the use of rigorous classical biochemical and cell-based approaches with state-of-the-art imaging methods, including live-cell single-particle tracking and cryo-electron tomography. These efforts will surely reveal fascinating insights into the ever-changing landscape of interactions between viruses and host cells. More importantly, they should also provide practical information that better positions the virology community to combat unresolved or new viral diseases.

PowerPoint slides {#Sec8}
=================
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Morphogenesis

:   The process by which a virus particle changes its shape and structure.

SEC61 translocation channel

:   An endoplasmic reticulum (ER) membrane protein complex that translocates nascent polypeptide chains from the cytosol into the lumen of the ER.

Post-translational modifications

:   Enzyme-mediated, covalent additions to proteins that often occur after biosynthesis.

ER chaperones

:   Endoplasmic reticulum (ER)-resident proteins that assist in the correct folding and unfolding of nascent polypeptide chains or macromolecular structures.

COPII-coated vesicles

:   (Coat protein complex II (COPII)-coated vesicles) Vesicles covered with a protein coat that buds from the endoplasmic reticulum (ER) membrane that transport cargos to the *cis*-Golgi.

Classical secretory pathway

:   An intracellular route that transports cargos from the endoplasmic reticulum (ER) to the Golgi apparatus and to the plasma membrane.

Progressive multifocal leukoencephalopathy

:   A rare, demyelinating disease of the brain.

Merkel cell carcinoma

:   A rare but aggressive type of neuroendocrine skin cancer.

Receptor-mediated endocytosis

:   An intracellular transport process in which a ligand binds to a receptor on the plasma membrane, thereby inducing the internalization of the receptor--ligand complex.

Endolysosomal system

:   A cellular membranous system that is composed of endosomes and lysosomes.

J protein

:   A molecular co-chaperone that contains a conserved ∼70 amino acid DNAJ domain (J domain), which stimulates the activity of the heat shock protein 70 (HSP70) chaperone.

Golgi apparatus

:   A cellular organelle that processes cargos and other macromolecules, packaging them into vesicles for delivery to the plasma membrane or to the endoplasmic reticulum.

Viroporin

:   A viral hydrophobic protein that perforates and disrupts the integrity of membranes.

ER-resident signal peptidase

:   An endoplasmic reticulum (ER)-localized enzyme that removes the amino-terminal signal sequence of a nascent polypeptide chain.

F-BAR domain

:   (Bin--amphiphysin--Rvs domain). A protein domain that is used to promote membrane curvature.

Inositol-requiring enzyme 1 (IRE1)-dependent decay pathway

:   A pathway that degrades mRNAs that encode endoplasmic reticulum (ER) membrane and secreted proteins through the cytoplasmic endonuclease domain of IRE1.

Autophagy

:   A cellular degradative mechanism of recycling unwanted components to provide nutrients and maintain cellular survival.
